People: Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

40.06USD
19 Dec 2014
Price Change (% chg)

$-0.29 (-0.72%)
Prev Close
$40.35
Open
$40.24
Day's High
$40.58
Day's Low
$38.23
Volume
1,532,488
Avg. Vol
757,904
52-wk High
$40.58
52-wk Low
$27.51

Search Stocks

Rogers, Michael 

Brief Biography

Mr. Michael W. Rogers is a Chief Financial Officer of Acorda Therapeutics Inc. Mr. Rogers joins Acorda with 22 years of experience in the biopharmaceutical industry. Most recently, he served as Executive Vice President and CFO of BG Medicine, Inc., where he led the company's successful initial public offering (IPO) in 2011 and was instrumental in assisting in the launch of that company's first product in the cardiovascular area. Prior to that, Mr. Rogers served as the CFO of Indevus Pharmaceuticals for 10 years until the company's sale to Endo Pharmaceuticals. He has led multiple private and public financings and had a central role in numerous mergers and acquisitions over the course of his career, which includes both in-house leadership positions and serving as an external financial advisor.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
241,139 -- 2,474,140 4,352,770

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Ron Cohen

3,918,020

Michael Rogers

4,352,770

Lauren Sabella

1,060,110

Andrew Blight

1,484,560

Jane Wasman

2,159,620

Enrique Carrazana

1,618,840
As Of 30 Dec 2013
Search Stocks